FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q4 2018

Top Holdings97 positions

Checking export access…
Activity:
SPYSPY
CALL

SPDR S&P 500 ETF TR

7.5M$1.9B13.7%———
First report
—
AABAAABADelisted
Fund

ALTABA INC

27.6M$1.6B11.7%——
1 qtr
First report
0
12.8M$615.6M4.5%——
1 qtr
First report
0

ALPHABET INC

464,405$480.9M3.5%$51.290.00%
1 qtr
First report
0
RHTRHTDelisted

RED HAT INC

2.7M$471.6M3.5%——
1 qtr
First report
0

META PLATFORMS INC

3.1M$400M2.9%$132.280.00%
1 qtr
First report
0
EQIXEQIX
REIT

EQUINIX INC

1.1M$391.7M2.9%$309.480.00%
1 qtr
First report
0

WABTEC

5.5M$388.6M2.8%$67.120.00%
1 qtr
First report
0

IQVIA HLDGS INC

3.2M$374M2.7%$113.910.00%
1 qtr
First report
0
7.7M$370.1M2.7%$10.64+200.85%
1 qtr
First report
0

CHARTER COMMUNICATIONS INC N

1.1M$307.9M2.3%$285.080.00%
1 qtr
First report
0

VISA INC

2.3M$306.1M2.2%$124.910.00%
1 qtr
First report
0

TRANSUNION

5.3M$299.3M2.2%$54.080.00%
1 qtr
First report
0

BOOKING HOLDINGS INC

165,482$285M2.1%$67.630.00%
1 qtr
First report
0
5.9M$284M2.1%——
1 qtr
First report
0

ELEVANCE HEALTH INC

1.1M$275.8M2.0%$236.130.00%
1 qtr
First report
0

MICROSOFT CORP

2.6M$263M1.9%$94.430.00%
1 qtr
First report
0

GENERAL DYNAMICS CORP

1.6M$256M1.9%$131.310.00%
1 qtr
First report
0
PLYAPLYADelisted

PLAYA HOTELS & RESORTS NV

30.6M$220.1M1.6%——
1 qtr
First report
0

THE CIGNA GROUP

1.1M$200.4M1.5%$174.340.00%
1 qtr
First report
0
$13.6B
AUM
97
Positions
Q4 2018
Filing
HI score · 1.0/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
Q4'18

First report: nothing earlier to compare

Composition
Equity vs derivatives
Equity84%Puts3%Calls14%
Holding period
<1Q100%1-4Q0%1-2Y0%2Y+0%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $13.6B across 97 positions as of Q4 2018. Top holdings: SPY calls (13.7%), AABA (11.7%), NWS/A (4.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.

Q4 2018 Summary

First quarter we have for this fund: 97 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $13.6B across 97 positions.

Top holdings by portfolio weight

Total AUM$11B
AABA11.73%
NWS/A4.51%
GOOG3.53%
RHT3.46%
META2.93%
EQIX2.87%
WAB2.85%
IQV2.74%
NWS2.71%
CHTR2.26%
Other2.24%

Portfolio allocation by GICS sector

Sectors10
Unknown42.37%
Healthcare15.95%
Communication Services13.74%
Industrials8.83%
Technology5.92%
Financial Services5.40%
Real Estate3.83%
Consumer Cyclical3.78%
Consumer Defensive0.16%
Utilities0.02%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown, Healthcare, Communication Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L48
Conviction44
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+9M shares+$755.7M
7Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q4 2024 → Q2 2026+7.8M shares+$277M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 → Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used